Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II

Submitted: November 24, 2015
Accepted: November 24, 2015
Published: November 24, 2015
Abstract Views: 1667
PDF: 1075
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. After the evaluation of the results obtained from gene therapy and stem cells, in this part we evaluate micro- RNA, post-translational modification and microspheres based therapy.



PlumX Metrics


Download data is not yet available.


How to Cite

Salzano, Andrea, Domenico Sirico, Michele Arcopinto, Alberto Maria Marra, Germano Guerra, Aldo Rocca, Alessandra Grieco, Francesco Giallauria, and Carlo Vigorito. 2015. “Anti Remodeling Therapy: New Strategies and Future Perspective in Post-Ischemic Heart Failure. Part II”. Monaldi Archives for Chest Disease 82 (4).

Similar Articles

You may also start an advanced similarity search for this article.